Metabolic Management
|
July 23, 2024

Insulin Resistance Vs. Prediabetes: What You Need To Know

Medically Reviewed by
Updated On
October 1, 2024

Understanding the nuances between insulin resistance and prediabetes is essential in the context of public health, especially considering that an average of 1 in 3 people in the US grapple with prediabetes and insulin resistance. 

This article elucidates the intricate relationship between these conditions and their diagnostic disparities and advocates for lifestyle modifications to mitigate their impact. By fostering comprehension, it empowers individuals to take proactive steps towards better metabolic health.

[signup]

What Is Insulin Resistance?

Insulin is a hormone released by the pancreas that helps to maintain healthy blood sugar homeostasis by pulling excess glucose out of the blood and storing it in muscle tissue. It also reduces glucose production in the liver when overall blood sugar levels are adequate. 

Insulin resistance is a condition in which these processes are disrupted due to the inability of cells to respond to insulin's signals effectively. If prolonged, insulin resistance can eventually lead to metabolic disorders such as type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).

Causes and Risk Factors

Common causes and risk factors for insulin resistance include:

What Is Prediabetes?

Prediabetes is a condition in which blood sugar levels are elevated above normal but not to a high enough threshold to be diagnosed as type 2 diabetes. In prediabetes, the pancreas can no longer produce enough insulin to regulate blood sugar levels within the body, leading to high blood glucose. It is often found incidentally as part of a routine screening lab work or is identified using an oral glucose tolerance test. 

Diagnostic parameters for prediabetes are as follows:

  • 12-hour fasting blood glucose: 100 mg/dL to 125 mg/dL
  • Hemoglobin A1c: 5.7% to 6.4%
  • Oral glucose tolerance test: 140 mg/dL to 199 mg/dL

Although often viewed as a precursor to type 2 diabetes, prediabetes is in itself a pathological state. It has important implications on blood sugar dysregulation, pancreatic function, vascular health, kidney health, and inflammation. It has been linked to increased risk for cardiovascular disease, cancer, and dementia, even in cases that do not progress to full-blown diabetes (19). 

Insulin Resistance & Prediabetes: What Is The Connection?

Insulin resistance is often the first step along the pathway to type 2 diabetes and other metabolic disorders, with prediabetes often following as the condition progresses. 

During insulin resistance, the muscle and liver cells stop responding to insulin signals, ultimately leading to temporary elevations in blood sugar. The pancreas responds by pumping out more insulin to return blood sugar levels to a healthy range successfully.

In contrast, in prediabetes, the pancreas reaches a point when it can no longer produce enough insulin to maintain blood sugar homeostasis, resulting in persistent blood glucose dysregulation (33). 

Generally, insulin resistance precedes the development of type 2 diabetes by 10-15 years, while prediabetes precedes diabetes by 5 years

Insulin Resistance Vs. Prediabetes: Key Differences

The main difference between insulin resistance and prediabetes is in regard to pancreatic function. 

  • In insulin resistance, although pancreatic processes are increased, they are still able to manage blood sugar levels effectively. 
  • In prediabetes, pancreatic cells can no longer compensate for reduced insulin sensitivity, resulting in persistent elevations in blood sugar. 

Clinically, prediabetes is easier to identify and monitor as blood glucose tests such as fasting blood glucose and hemoglobin A1c will show up as abnormal.  In insulin resistance, these may still fall within the normal range. 

Routine testing for insulin resistance is not performed by most healthcare providers as direct markers are often complicated and expensive, though surrogate markers such as fasting insulin and HOMA-IR are sometimes used. Instead, diagnosis often occurs in later stages when insulin resistance is already accompanied by related metabolic conditions. 

The overall consequence is that prediabetes offers a clinical intervention point to stop the progression, whereas insulin resistance usually goes unnoticed and untreated even though it is more easily reversed. 

Signs and Symptoms

Insulin resistance can often be asymptomatic, but its presence is more likely when the following are present: 

Similar to insulin resistance, most people with prediabetes do not develop symptoms. However, those who are symptomatic can present with the following:

  • Increased hunger
  • Weight gain
  • Fatigue
  • Weakness
  • Blurry vision
  • Cuts or bruises that take long to heal

Because prediabetes is not often accompanied by noticeable symptoms, it is important that it be regularly screened via laboratory testing for those at risk. 

Prevention and Management

Both prediabetes and insulin resistance are highly associated with physical inactivity and overweight status. Therefore, lifestyle interventions are at the cornerstone of preventing and managing these conditions. 

  • Diets, such as the Mediterranean diet that prioritize high fiber intake from fruits and vegetables, whole grains, lean proteins, and fats that limit processed foods and sweets. are associated with decreased risk of type 2 diabetes and improved glycemic control (20). 
  • Additionally, regular aerobic exercise has been shown to reduce fasting blood glucose and hemoglobin A1c levels, reduce central obesity, and increase insulin sensitivity in patients with prediabetes and insulin resistance. 

When to See a Doctor

The US Preventive Services Task Force recommends screening annually for prediabetes and type 2 diabetes in individuals who are overweight and between the ages of 35 and 70. No official screening guidelines exist for insulin resistance. 

Signs of Worsening Conditions

Patients who are symptomatic or have multiple risk factors for prediabetes and insulin resistance should consult with their healthcare provider, as catching these conditions early can help reduce their progression into more serious diseases. 

If the following symptoms develop, immediate medical attention is warranted as type 2 diabetes may be likely:

  • Frequent urination
  • Extreme hunger and/or thirst
  • Fatigue
  • Blurred vision
  • Slow healing of cuts and bruises
  • Numbness and tingling in the hands and feet
  • Unexpected weight loss

[signup]

Key Takeaways

  • Identifying insulin resistance and prediabetes is vital for early intervention and prevention. Understanding their connection illuminates the path towards better metabolic health. 
  • Insulin resistance occurs when there is impairment in insulin signaling. This leads to higher than normal output of insulin from the pancreas to control blood glucose levels.
  • Prediabetes is a condition in which the pancreas increases insulin secretion but is unable to effectively lower blood glucose levels, resulting in sustained elevations of blood sugar. 
  • Both conditions have important health implications, including increased risk for the development of diabetes.
  • Lifestyle adjustments, such as diet and exercise, play pivotal roles in managing these conditions. By heeding warning signs, undergoing regular screenings, and adopting healthy habits, individuals can mitigate their risks and pave the way toward a healthier future.

Understanding the nuances between insulin resistance and prediabetes is essential in the context of public health, especially considering that an average of 1 in 3 people in the US grapple with prediabetes and insulin resistance. 

This article explores the relationship between these conditions and their diagnostic differences and suggests lifestyle changes that may help manage their impact. By fostering understanding, it encourages individuals to take steps towards supporting better metabolic health.

[signup]

What Is Insulin Resistance?

Insulin is a hormone released by the pancreas that helps to maintain healthy blood sugar levels by moving excess glucose out of the blood and storing it in muscle tissue. It also reduces glucose production in the liver when overall blood sugar levels are adequate. 

Insulin resistance is a condition in which these processes are disrupted due to the inability of cells to respond to insulin's signals effectively. If prolonged, insulin resistance can eventually contribute to metabolic disorders such as type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).

Causes and Risk Factors

Common causes and risk factors for insulin resistance include:

What Is Prediabetes?

Prediabetes is a condition in which blood sugar levels are elevated above normal but not to a high enough threshold to be diagnosed as type 2 diabetes. In prediabetes, the pancreas may struggle to produce enough insulin to regulate blood sugar levels within the body, leading to high blood glucose. It is often found incidentally as part of a routine screening lab work or is identified using an oral glucose tolerance test. 

Diagnostic parameters for prediabetes are as follows:

  • 12-hour fasting blood glucose: 100 mg/dL to 125 mg/dL
  • Hemoglobin A1c: 5.7% to 6.4%
  • Oral glucose tolerance test: 140 mg/dL to 199 mg/dL

Although often viewed as a precursor to type 2 diabetes, prediabetes is in itself a condition that affects blood sugar regulation, pancreatic function, vascular health, kidney health, and inflammation. It has been linked to increased risk for cardiovascular disease, cancer, and dementia, even in cases that do not progress to full-blown diabetes (19). 

Insulin Resistance & Prediabetes: What Is The Connection?

Insulin resistance is often the first step along the pathway to type 2 diabetes and other metabolic conditions, with prediabetes often following as the condition progresses. 

During insulin resistance, the muscle and liver cells may not respond to insulin signals effectively, leading to temporary elevations in blood sugar. The pancreas responds by producing more insulin to help return blood sugar levels to a healthy range.

In contrast, in prediabetes, the pancreas may reach a point when it can no longer produce enough insulin to maintain blood sugar balance, resulting in persistent blood glucose dysregulation (33). 

Generally, insulin resistance may precede the development of type 2 diabetes by 10-15 years, while prediabetes may precede diabetes by 5 years

Insulin Resistance Vs. Prediabetes: Key Differences

The main difference between insulin resistance and prediabetes is in regard to pancreatic function. 

  • In insulin resistance, although pancreatic processes are increased, they may still manage blood sugar levels effectively. 
  • In prediabetes, pancreatic cells may no longer compensate for reduced insulin sensitivity, resulting in persistent elevations in blood sugar. 

Clinically, prediabetes is easier to identify and monitor as blood glucose tests such as fasting blood glucose and hemoglobin A1c will show up as abnormal.  In insulin resistance, these may still fall within the normal range. 

Routine testing for insulin resistance is not performed by most healthcare providers as direct markers are often complicated and expensive, though surrogate markers such as fasting insulin and HOMA-IR are sometimes used. Instead, diagnosis often occurs in later stages when insulin resistance is already accompanied by related metabolic conditions. 

The overall consequence is that prediabetes offers a clinical intervention point to help manage progression, whereas insulin resistance usually goes unnoticed and untreated even though it may be more easily managed with lifestyle changes. 

Signs and Symptoms

Insulin resistance can often be asymptomatic, but its presence is more likely when the following are present: 

Similar to insulin resistance, most people with prediabetes do not develop symptoms. However, those who are symptomatic can present with the following:

  • Increased hunger
  • Weight gain
  • Fatigue
  • Weakness
  • Blurry vision
  • Cuts or bruises that take long to heal

Because prediabetes is not often accompanied by noticeable symptoms, it is important that it be regularly screened via laboratory testing for those at risk. 

Prevention and Management

Both prediabetes and insulin resistance are highly associated with physical inactivity and overweight status. Therefore, lifestyle interventions are at the cornerstone of supporting the management of these conditions. 

  • Diets, such as the Mediterranean diet that prioritize high fiber intake from fruits and vegetables, whole grains, lean proteins, and fats that limit processed foods and sweets, are associated with decreased risk of type 2 diabetes and improved glycemic control (20). 
  • Additionally, regular aerobic exercise has been shown to support healthy fasting blood glucose and hemoglobin A1c levels, reduce central obesity, and increase insulin sensitivity in patients with prediabetes and insulin resistance. 

When to See a Doctor

The US Preventive Services Task Force recommends screening annually for prediabetes and type 2 diabetes in individuals who are overweight and between the ages of 35 and 70. No official screening guidelines exist for insulin resistance. 

Signs of Worsening Conditions

Patients who are symptomatic or have multiple risk factors for prediabetes and insulin resistance should consult with their healthcare provider, as catching these conditions early can help manage their progression into more serious diseases. 

If the following symptoms develop, immediate medical attention is warranted as type 2 diabetes may be likely:

  • Frequent urination
  • Extreme hunger and/or thirst
  • Fatigue
  • Blurred vision
  • Slow healing of cuts and bruises
  • Numbness and tingling in the hands and feet
  • Unexpected weight loss

[signup]

Key Takeaways

  • Identifying insulin resistance and prediabetes is vital for early intervention and prevention. Understanding their connection can help guide individuals towards better metabolic health. 
  • Insulin resistance occurs when there is impairment in insulin signaling. This leads to higher than normal output of insulin from the pancreas to help manage blood glucose levels.
  • Prediabetes is a condition in which the pancreas increases insulin secretion but may not effectively lower blood glucose levels, resulting in sustained elevations of blood sugar. 
  • Both conditions have important health implications, including increased risk for the development of diabetes.
  • Lifestyle adjustments, such as diet and exercise, play pivotal roles in managing these conditions. By heeding warning signs, undergoing regular screenings, and adopting healthy habits, individuals can support their health and pave the way toward a healthier future.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. About Prediabetes and Type 2 Diabetes | National Diabetes Prevention Program | CDC. (2023, November 15). Www.cdc.gov. https://www.cdc.gov/diabetes-prevention/about-prediabetes-type-2/?CDC_AAref_Val=https://www.cdc.gov/diabetes/prevention/about-prediabetes.html
  2. Achuff, J. (2024, February 6). How to Lower Your Patient’s Triglycerides Using Root Cause Medicine. Rupa Health. https://www.rupahealth.com/post/how-to-lower-your-patients-triglycerides-using-root-cause-medicine
  3. Anderson, S. (2022, July 22). 5 conditions that make it harder to lose weight. Rupa Health. https://www.rupahealth.com/post/cant-lose-weight-these-5-medical-problems-may-be-why
  4. Bertagna, B. (2023, December 11). Olive Oil For Diabetes: How The Mediterranean Diet Can Help Prevent This Condition. Rupa Health. https://www.rupahealth.com/post/olive-oil-for-diabetes-how-the-mediterranean-diet-can-help-prevent-this-condition
  5. Brady, M. F., & Rawla, P. (2019, April 6). Acanthosis nigricans. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK431057/
  6. Cloyd, J. (2023a, March 7). An integrative medicine approach to fatigue. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-fatigue
  7. Cloyd, J. (2023b, July 20). A functional medicine PCOS protocol: Comprehensive testing, therapeutic diet, and supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-pcos-protocol-comprehensive-testing-therapeutic-diet-and-supplements
  8. Cloyd, J. (2023c, December 1). A Functional Medicine Protocol For Balancing Blood Sugar. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-for-balancing-blood-sugar
  9. Cloyd, J. (2024a, January 2). A Functional Medicine Approach to Prediabetes. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-prediabetes
  10. Cloyd, J. (2024b, January 17). HbA1c Testing: A Crucial Tool for Diabetes Management in Functional Medicine. Rupa Health. https://www.rupahealth.com/post/hba1c-testing-a-crucial-tool-for-diabetes-management-in-functional-medicine
  11. Cloyd, J. (2024c, March 1). What is Hyperlipidemia? Symptoms, Testing, and Treatments. Rupa Health. https://www.rupahealth.com/post/what-is-hyperlipidemia-symptoms-testing-and-treatments
  12. Cloyd, J. (2024d, April 11). The Vicious Cycle of Obesity, Diabetes, and Hypertension: Breaking Free. Rupa Health. https://www.rupahealth.com/post/the-vicious-cycle-of-obesity-diabetes-and-hypertension-breaking-free
  13. US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., Kubik, M., Li, L., Ogedegbe, G., Owens, D. K., Pbert, L., Silverstein, M., Stevermer, J., Tseng, C. W., & Wong, J. B. (2021). Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 325(19), 1965–1977. https://doi.org/10.1001/jama.2021.6238
  14. Freeman, A. M., & Pennings, N. (2023). Insulin Resistance. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507839/
  15. goldmanb @stanford.edu, img src=’/content/dam/sm-news/images/2019/11/goldman-bruce-90 jpg img 620 high png/1574888938204 png’ alt=’Bruce G. B. G. B. G. is a science writer in the O. of C. E. him at. (2021, September 22). Insulin resistance doubles risk of major depressive disorder, Stanford study finds. News Center. https://med.stanford.edu/news/all-news/2021/09/insulin-resistance-major-depressive-disorder.html
  16. Greenan, S. (2021, October 11). 7 Early Signs Of Insulin Resistance. Rupa Health. https://www.rupahealth.com/post/what-is-insulin-resistance
  17. Henry, E. (2021, September 29). Are Your Patients Insulin Resistant? 4 Ways To Test. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-testing
  18. Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs
  19. Lawal, Y., Bello, F., & Kaoje, Y. S. (2020). Prediabetes Deserves More Attention: A Review. Clinical Diabetes, 38(4), cd190101. https://doi.org/10.2337/cd19-0101
  20. Martín-Peláez, S., Fito, M., & Castaner, O. (2020). Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review. Nutrients, 12(8), 2236. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468821/
  21. Mishra, S. (2013). Effect of Physical activity on Insulin Resistance, Inflammation and Oxidative Stress in Diabetes Mellitus. JOURNAL of CLINICAL and DIAGNOSTIC RESEARCH, 7(8). https://doi.org/10.7860/jcdr/2013/6518.3306
  22. Muniyappa, R., & Madan, R. (2000). Assessing Insulin Sensitivity and Resistance in Humans (K. R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W. W. de Herder, K. Dungan, A. Grossman, J. M. Hershman, H. J. Hofland, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, J. Purnell, F. Singer, C. A. Stratakis, & D. L. Trence, Eds.). PubMed; MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK278954/
  23. National Institute of Diabetes and Digestive and Kidney Diseases. (2017, May). Type 2 Diabetes . National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/type-2-diabetes
  24. Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease
  25. Rahman, S. (2021). Role of insulin in health and disease: An update. International Journal of Molecular Sciences, 22(12), 6403. https://doi.org/10.3390/ijms22126403
  26. Shantal Alvarez, & Algotar, A. M. (2019, January 28). Prediabetes. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459332/
  27. Stanford, J. (2024a, March 4). Dementia Actually Type 3 Diabetes? The Role of Insulin Resistance. Rupa Health. https://www.rupahealth.com/post/dementia-actually-type-3-diabetes-the-role-of-insulin-resistance
  28. Stanford, J. (2024b, March 19). Exploring the Link Between Insulin Resistance and Obesity. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-obesity
  29. Stanford, J. (2024c, March 21). Insulin Resistance and Inflammation: Understanding the Connection. Rupa Health. https://www.rupahealth.com/post/insulin-resistance-and-inflammation-understanding-the-connection
  30. Sweetnich, J. (2023a, March 15). Sodium 101: Lab Tests, Disorders, & How Much To Consume Daily. Rupa Health. https://www.rupahealth.com/post/sodium-101
  31. Sweetnich, J. (2023b, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management
  32. Sweetnich, J. (2023c, May 24). Overview of The Pancreas: Top Conditions, Specialty Testing, and Integrative Medicine Treatment Options. Rupa Health. https://www.rupahealth.com/post/pancrease-101-with-testing-top-conditions
  33. Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet, 379(9833), 2279–2290. https://doi.org/10.1016/s0140-6736(12)60283-9
  34. Weinberg, J. (2022, May 3). Tiredness, weight loss, and itching are signs of this dangerous liver disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-non-alcoholic-fatty-liver-disease
  35. Yoshimura, H. (2023, November 13). Sweat It Out: The Powerful Connection Between Exercise and Insulin Sensitivity. Rupa Health. https://www.rupahealth.com/post/sweat-it-out-the-powerful-connection-between-exercise-and-insulin-sensitivity
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Metabolic Management
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a Free Live Class that dives into how popular diets impact the gut microbiome, the clinical dietary needs of your gut, biomarkers to test to analyze gut health, and gain a clear understanding of the Doctor’s Data GI360™ profile. Register here.